BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Tardive Dyskinesia Movement

Below is an extended Tardive Dyskinesia Movement research listing. Click here to return to the Tardive Dyskinesia Movement main in depth entry.

Recent Publications on Tardive Dyskinesia Movement:

The rabbit syndrome: state of the art. 12th August, 2008
Dipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie,
Ziprasidone-induced tardive laryngeal dystonia: a case report.
Tardive laryngeal dystonia, a rare form of dystonic syndrome, was only...
Direct Link
12th August, 2008
Department of Psychiatry, Chang Gung Memorial Hospital-Kaohsiung Medical
Pyridoxal plasma level in schizophrenic and schizoaffective patients with and without tardive dyskinesia.
BACKGROUND: Motor disturbances in vitamin B6-deficient animals were...
Direct Link
2nd August, 2008
Division of Psychiatry, Ministry of Health Be'er Sheva Mental Health
The impact of olanzapine on tardive dyskinetic symptoms in a state hospital population.
BACKGROUND: Tardive dyskinesia is a serious adverse event, which is...
Direct Link
18th July, 2008
School of Medicine, Western Psychiatric Institute & Clinic and University
Acculturation is associated with the prevalence of tardive dyskinesia and akathisia in community-treated patients with schizophrenia.
OBJECTIVE: Ethnicity is a risk factor for tardive dyskinesia (TD) and...
Direct Link
9th July, 2008
Northern Psychiatry Research Centre and Northern Area Mental Health
Drug-induced tardive syndromes. 2nd July, 2008
Department of Neurology, Hospital Universitario Principe de Asturias,
The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment.
Abstract Tardive dyskinesia (TD) is associated with polymorphisms of the...
Direct Link
20th June, 2008
Department of Pharmacotherapy and Pharmaceutical Care, GUIDE, University
Effects of levetiracetam on tardive dyskinesia: a randomized, double-blind, placebo-controlled study. 17th June, 2008
Department of Psychiatry, Yale University, Connecticut Mental Health
Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia.
Some patients treated chronically with antipsychotics develop tardive...
Direct Link
13th June, 2008
Department of Psychiatry, Taipei Veterans General Hospital, Taipei,
Metoclopramide, an increasingly recognized cause of tardive dyskinesia.
Medium spiny neurons (MSNs) provide the principal output for the dorsal...
Direct Link
20th May, 2008
Parkinson's Disease Center and Movement Disorders Clinic, Department of
Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.
OBJECTIVE: Neuroleptic-induced tardive dyskinesia (TD) is an involuntary...
Direct Link
2nd May, 2008
Seiwa Hospital, Institute of Neuropsychiatry, Benten-cho 91, Shinjuku-ku,
Val158Met polymorphism in the catechol-O-methyltransferase (COMT) gene is not associated with tardive dyskinesia in schizophrenia.
OBJECTIVE: This study investigated whether the...
Direct Link
22nd April, 2008
Department of Psychiatry, Korea University College of Medicine, Seoul,
Neuroleptic-induced movement disorders in a naturalistic schizophrenia population: diagnostic value of actometric movement patterns.
BACKGROUND: Neuroleptic-induced movement disorders (NIMDs) have...
Direct Link
19th April, 2008
Department of Psychiatry, University of Tartu, Raja 31, 50417, Tartu,
Tourette's syndrome. 4th April, 2008
Department of Neurology, Baylor College of Medicine, Houston, Texas 77030,
Differential tonic GABA conductances in striatal medium spiny neurons.
Medium spiny neurons (MSNs) provide the principal output for the dorsal...
Direct Link
20th February, 2008
Department of Physiology and Biophysics, Georgetown University School of
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional